| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Jul 1, 2026 | Option exercise(M) | 80K | $2.08 | $166K | 747K |
| Jul 1, 2026 | Sell(S) | 2K | $112.80 | $212K | 745K |
| Jul 1, 2026 | Sell(S) | 7K | $113.98 | $755K | 738K |
| Jul 1, 2026 | Sell(S) | 24K | $114.96 | $2.8M | 714K |
| Jul 1, 2026 | Sell(S) | 44K | $115.69 | $5.1M | 670K |
| Jul 1, 2026 | Sell(S) | 3K | $116.56 | $389K | 667K |
| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Jul 1, 2026 | Option exercise(M) | 80K | — | $0 | 136K |
Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-295088) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for Kymera Therapeutics, Inc.
This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/filing/0001193125-26-295088"
Use Arkolith to summarize insider buying and selling at Kymera Therapeutics, Inc. over the last 90 days and cite the filings.